Treatment of giardiasis: current status and future directions.

Title

Treatment of giardiasis: current status and future directions.

Creator

Watkins Richard R; Eckmann Lars

Publisher

Current infectious disease reports

Date

2014
2014-02

Description

Giardiasis is a common yet neglected cause of diarrheal illness worldwide. Antimicrobial therapy is usually but not always effective and drug resistance has become an increasing concern. Several promising drug candidates have been recently identified that can overcome antibiotic resistance in Giardia. These include derivatives of 5-nitroimidazoles and benzimidazoles, as well as hybrid compounds created from combinations of different antigiardial drugs. High-throughput screening of large compound libraries has been a productive strategy for identifying antigiardial activity in drugs already approved for other indications, e.g. auranofin. This article reviews the current treatment of giardiasis, mechanisms of resistance, advances in drug and vaccine development, and directions for further research on this significant human pathogen.

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

396–396

Issue

2

Volume

16

Citation

Watkins Richard R; Eckmann Lars, “Treatment of giardiasis: current status and future directions.,” NEOMED Bibliography Database, accessed June 21, 2021, https://neomed.omeka.net/items/show/3259.

Social Bookmarking